| UniProt ID | VPS45_HUMAN | |
|---|---|---|
| UniProt AC | Q9NRW7 | |
| Protein Name | Vacuolar protein sorting-associated protein 45 | |
| Gene Name | VPS45 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 570 | |
| Subcellular Localization |
Golgi apparatus membrane Peripheral membrane protein. Endosome membrane Peripheral membrane protein. Associated with Golgi/endosomal vesicles and the trans-Golgi network.. |
|
| Protein Description | May play a role in vesicle-mediated protein trafficking from the Golgi stack through the trans-Golgi network.. | |
| Protein Sequence | MNVVFAVKQYISKMIEDSGPGMKVLLMDKETTGIVSMVYTQSEILQKEVYLFERIDSQNREIMKHLKAICFLRPTKENVDYIIQELRRPKYTIYFIYFSNVISKSDVKSLAEADEQEVVAEVQEFYGDYIAVNPHLFSLNILGCCQGRNWDPAQLSRTTQGLTALLLSLKKCPMIRYQLSSEAAKRLAECVKQVITKEYELFEFRRTEVPPLLLILDRCDDAITPLLNQWTYQAMVHELLGINNNRIDLSRVPGISKDLREVVLSAENDEFYANNMYLNFAEIGSNIKNLMEDFQKKKPKEQQKLESIADMKAFVENYPQFKKMSGTVSKHVTVVGELSRLVSERNLLEVSEVEQELACQNDHSSALQNIKRLLQNPKVTEFDAARLVMLYALHYERHSSNSLPGLMMDLRNKGVSEKYRKLVSAVVEYGGKRVRGSDLFSPKDAVAITKQFLKGLKGVENVYTQHQPFLHETLDHLIKGRLKENLYPYLGPSTLRDRPQDIIVFVIGGATYEEALTVYNLNRTTPGVRIVLGGTTVHNTKSFLEEVLASGLHSRSKESSQVTSRSASRR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 10 | Phosphorylation | VVFAVKQYISKMIED HHHHHHHHHHHHHHH | 11.05 | 22817900 | |
| 18 | Phosphorylation | ISKMIEDSGPGMKVL HHHHHHHCCCCCEEE | 33.81 | 29978859 | |
| 64 | Ubiquitination | SQNREIMKHLKAICF HCCHHHHHHHHHHHH | 51.99 | - | |
| 75 | Phosphorylation | AICFLRPTKENVDYI HHHHHCCCHHHHHHH | 44.55 | 30576142 | |
| 76 | Ubiquitination | ICFLRPTKENVDYII HHHHCCCHHHHHHHH | 50.39 | - | |
| 81 | Phosphorylation | PTKENVDYIIQELRR CCHHHHHHHHHHHHC | 8.81 | - | |
| 158 | Phosphorylation | DPAQLSRTTQGLTAL CHHHHHHHHHHHHHH | 21.79 | 20068231 | |
| 159 | Phosphorylation | PAQLSRTTQGLTALL HHHHHHHHHHHHHHH | 21.38 | 20068231 | |
| 163 | Phosphorylation | SRTTQGLTALLLSLK HHHHHHHHHHHHHHC | 23.29 | 20068231 | |
| 168 | Phosphorylation | GLTALLLSLKKCPMI HHHHHHHHHCCCCCH | 37.80 | 24719451 | |
| 170 | Ubiquitination | TALLLSLKKCPMIRY HHHHHHHCCCCCHHH | 49.29 | 21890473 | |
| 170 | Ubiquitination | TALLLSLKKCPMIRY HHHHHHHCCCCCHHH | 49.29 | 21890473 | |
| 171 | Ubiquitination | ALLLSLKKCPMIRYQ HHHHHHCCCCCHHHH | 49.19 | - | |
| 185 | Ubiquitination | QLSSEAAKRLAECVK HCCHHHHHHHHHHHH | 55.80 | 21906983 | |
| 192 | Acetylation | KRLAECVKQVITKEY HHHHHHHHHHHHHCH | 50.97 | 25953088 | |
| 192 | Ubiquitination | KRLAECVKQVITKEY HHHHHHHHHHHHHCH | 50.97 | - | |
| 192 | Malonylation | KRLAECVKQVITKEY HHHHHHHHHHHHHCH | 50.97 | 26320211 | |
| 197 | Ubiquitination | CVKQVITKEYELFEF HHHHHHHHCHHHHCC | 47.37 | - | |
| 250 | Phosphorylation | NNNRIDLSRVPGISK CCCCCCHHHCCCCCH | 27.73 | 30387612 | |
| 257 | Ubiquitination | SRVPGISKDLREVVL HHCCCCCHHHHHHHH | 59.88 | 21890473 | |
| 257 | Ubiquitination | SRVPGISKDLREVVL HHCCCCCHHHHHHHH | 59.88 | 21890473 | |
| 272 | Phosphorylation | SAENDEFYANNMYLN HCCCCCHHHCCCEEE | 13.33 | - | |
| 296 | Ubiquitination | NLMEDFQKKKPKEQQ HHHHHHHHCCHHHHH | 63.86 | - | |
| 297 | Ubiquitination | LMEDFQKKKPKEQQK HHHHHHHCCHHHHHH | 64.62 | - | |
| 304 | Ubiquitination | KKPKEQQKLESIADM CCHHHHHHHHHHHHH | 54.65 | - | |
| 307 | Phosphorylation | KEQQKLESIADMKAF HHHHHHHHHHHHHHH | 33.25 | 26657352 | |
| 312 | Ubiquitination | LESIADMKAFVENYP HHHHHHHHHHHHHCH | 38.94 | 21906983 | |
| 318 | Phosphorylation | MKAFVENYPQFKKMS HHHHHHHCHHHHHCC | 5.72 | 25884760 | |
| 322 | 2-Hydroxyisobutyrylation | VENYPQFKKMSGTVS HHHCHHHHHCCCCCC | 42.17 | - | |
| 322 | Ubiquitination | VENYPQFKKMSGTVS HHHCHHHHHCCCCCC | 42.17 | - | |
| 322 | Methylation | VENYPQFKKMSGTVS HHHCHHHHHCCCCCC | 42.17 | 115978745 | |
| 323 | Methylation | ENYPQFKKMSGTVSK HHCHHHHHCCCCCCC | 39.32 | 115978753 | |
| 323 | Ubiquitination | ENYPQFKKMSGTVSK HHCHHHHHCCCCCCC | 39.32 | - | |
| 327 | Phosphorylation | QFKKMSGTVSKHVTV HHHHCCCCCCCCEEH | 17.82 | - | |
| 330 | Ubiquitination | KMSGTVSKHVTVVGE HCCCCCCCCEEHHHH | 37.45 | - | |
| 339 | Phosphorylation | VTVVGELSRLVSERN EEHHHHHHHHHHHCC | 21.18 | - | |
| 371 | Ubiquitination | SSALQNIKRLLQNPK HHHHHHHHHHHHCCC | 44.54 | - | |
| 378 | Ubiquitination | KRLLQNPKVTEFDAA HHHHHCCCCCHHHHH | 70.14 | 21906983 | |
| 418 | Ubiquitination | RNKGVSEKYRKLVSA HHCCCCHHHHHHHHH | 42.73 | - | |
| 419 (in isoform 2) | Phosphorylation | - | 14.66 | 27174698 | |
| 420 (in isoform 2) | Phosphorylation | - | 36.58 | 27174698 | |
| 424 | Phosphorylation | EKYRKLVSAVVEYGG HHHHHHHHHHHHCCC | 26.28 | 28857561 | |
| 430 (in isoform 2) | Phosphorylation | - | 22.95 | 27174698 | |
| 431 (in isoform 2) | Phosphorylation | - | 17.44 | 27174698 | |
| 432 | Malonylation | AVVEYGGKRVRGSDL HHHHCCCEECCCCCC | 43.27 | 26320211 | |
| 432 | Ubiquitination | AVVEYGGKRVRGSDL HHHHCCCEECCCCCC | 43.27 | - | |
| 435 (in isoform 2) | Phosphorylation | - | 42.82 | 27174698 | |
| 437 | Phosphorylation | GGKRVRGSDLFSPKD CCEECCCCCCCCHHH | 22.15 | 26471730 | |
| 441 | Phosphorylation | VRGSDLFSPKDAVAI CCCCCCCCHHHHHHH | 38.03 | 21815630 | |
| 443 | Ubiquitination | GSDLFSPKDAVAITK CCCCCCHHHHHHHHH | 58.06 | 21906983 | |
| 450 | Ubiquitination | KDAVAITKQFLKGLK HHHHHHHHHHHHHCC | 32.70 | 21890473 | |
| 450 | Ubiquitination | KDAVAITKQFLKGLK HHHHHHHHHHHHHCC | 32.70 | 21890473 | |
| 454 | Ubiquitination | AITKQFLKGLKGVEN HHHHHHHHHCCCCCC | 64.58 | - | |
| 457 | Ubiquitination | KQFLKGLKGVENVYT HHHHHHCCCCCCCCC | 70.36 | - | |
| 479 | Ubiquitination | ETLDHLIKGRLKENL HHHHHHHHCHHHHCC | 44.32 | - | |
| 483 | Malonylation | HLIKGRLKENLYPYL HHHHCHHHHCCCCCC | 43.10 | 26320211 | |
| 483 | Ubiquitination | HLIKGRLKENLYPYL HHHHCHHHHCCCCCC | 43.10 | 21890473 | |
| 483 | Ubiquitination | HLIKGRLKENLYPYL HHHHCHHHHCCCCCC | 43.10 | 21890473 | |
| 487 | Phosphorylation | GRLKENLYPYLGPST CHHHHCCCCCCCHHH | 11.04 | 28634120 | |
| 489 | Phosphorylation | LKENLYPYLGPSTLR HHHCCCCCCCHHHCC | 15.67 | 22210691 | |
| 494 | Phosphorylation | YPYLGPSTLRDRPQD CCCCCHHHCCCCCCC | 29.01 | 22210691 | |
| 511 | Phosphorylation | VFVIGGATYEEALTV EEEECCCCHHHHHHH | 34.44 | 22210691 | |
| 557 | Ubiquitination | SGLHSRSKESSQVTS CCCCCCCCCHHCCCC | 61.58 | - | |
| 559 | Phosphorylation | LHSRSKESSQVTSRS CCCCCCCHHCCCCCC | 29.79 | 25262027 | |
| 560 | Phosphorylation | HSRSKESSQVTSRSA CCCCCCHHCCCCCCC | 29.75 | 25262027 | |
| 563 | Phosphorylation | SKESSQVTSRSASRR CCCHHCCCCCCCCCC | 15.70 | 18077418 | |
| 564 | Phosphorylation | KESSQVTSRSASRR- CCHHCCCCCCCCCC- | 25.94 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of VPS45_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of VPS45_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VPS45_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ZN827_HUMAN | ZNF827 | physical | 22939629 | |
| RBNS5_HUMAN | RBSN | physical | 25416956 | |
| DAG1_HUMAN | DAG1 | physical | 26344197 | |
| RBNS5_HUMAN | RBSN | physical | 26344197 | |
| SCFD1_HUMAN | SCFD1 | physical | 26344197 | |
| VP33A_HUMAN | VPS33A | physical | 26344197 | |
| STX16_HUMAN | STX16 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 615285 | Neutropenia, severe congenital 5, autosomal recessive (SCN5) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...